Published in Adv Drug Deliv Rev on April 10, 2007
The differentiation of embryonic stem cells seeded on electrospun nanofibers into neural lineages. Biomaterials (2008) 1.58
Biomaterial design strategies for the treatment of spinal cord injuries. J Neurotrauma (2010) 1.40
Current tissue engineering and novel therapeutic approaches to axonal regeneration following spinal cord injury using polymer scaffolds. Respir Physiol Neurobiol (2009) 1.22
Metallic ions as therapeutic agents in tissue engineering scaffolds: an overview of their biological applications and strategies for new developments. J R Soc Interface (2011) 1.18
Plasmid releasing multiple channel bridges for transgene expression after spinal cord injury. Mol Ther (2008) 1.03
A review on composite liposomal technologies for specialized drug delivery. J Drug Deliv (2011) 1.00
Neural tissue engineering using embryonic and induced pluripotent stem cells. Stem Cell Res Ther (2011) 0.99
Nanofibrous collagen nerve conduits for spinal cord repair. Tissue Eng Part A (2012) 0.98
Adhesion molecule-modified biomaterials for neural tissue engineering. Front Neuroeng (2009) 0.98
Phosphatidylserine immobilization of lentivirus for localized gene transfer. Biomaterials (2010) 0.98
Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis. Expert Opin Drug Deliv (2011) 0.92
Hydrogels in spinal cord injury repair strategies. ACS Chem Neurosci (2011) 0.90
Organic electrode coatings for next-generation neural interfaces. Front Neuroeng (2014) 0.90
Fibrinogen and fibrin based micro and nano scaffolds incorporated with drugs, proteins, cells and genes for therapeutic biomedical applications. Int J Nanomedicine (2013) 0.90
The role of neurotrophic factors conjugated to iron oxide nanoparticles in peripheral nerve regeneration: in vitro studies. Biomed Res Int (2014) 0.89
A review of bioactive release from nerve conduits as a neurotherapeutic strategy for neuronal growth in peripheral nerve injury. Biomed Res Int (2014) 0.89
Combination therapies in the CNS: engineering the environment. Neurosci Lett (2012) 0.88
Regenerative medicine for the treatment of spinal cord injury: more than just promises? J Cell Mol Med (2012) 0.87
Vascular endothelial growth factor and fibroblast growth factor 2 delivery from spinal cord bridges to enhance angiogenesis following injury. J Biomed Mater Res A (2011) 0.86
Drug-eluting microfibrous patches for the local delivery of rolipram in spinal cord repair. J Control Release (2012) 0.85
Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration. Stem Cells Int (2015) 0.84
The Effect of Electrospun Gelatin Fibers Alignment on Schwann Cell and Axon Behavior and Organization in the Perspective of Artificial Nerve Design. Int J Mol Sci (2015) 0.83
The impact of prolapse mesh on vaginal smooth muscle structure and function. BJOG (2015) 0.82
Nanostructured guidance for peripheral nerve injuries: a review with a perspective in the oral and maxillofacial area. Int J Mol Sci (2014) 0.81
Neuronal Differentiation of Human Mesenchymal Stem Cells Using Exosomes Derived from Differentiating Neuronal Cells. PLoS One (2015) 0.79
Photoresponsive microvalve for remote actuation and flow control in microfluidic devices. Biomicrofluidics (2015) 0.78
Strategies for regeneration of components of nervous system: scaffolds, cells and biomolecules. Regen Biomater (2015) 0.78
Advanced Materials for Neural Surface Electrodes. Curr Opin Solid State Mater Sci (2014) 0.77
Advances in progenitor cell therapy using scaffolding constructs for central nervous system injury. Stem Cell Rev (2009) 0.77
Carriers in cell-based therapies for neurological disorders. Int J Mol Sci (2014) 0.77
Stem cells for spinal cord injury: Strategies to inform differentiation and transplantation. Biotechnol Bioeng (2016) 0.77
Improvements in biomaterial matrices for neural precursor cell transplantation. Mol Cell Ther (2014) 0.77
Strain tunes proteolytic degradation and diffusive transport in fibrin networks. Biomacromolecules (2012) 0.76
Poly(trimethylene carbonate-co-ε-caprolactone) promotes axonal growth. PLoS One (2014) 0.76
A comparison of the performance of mono- and bi-component electrospun conduits in a rat sciatic model. Biomaterials (2014) 0.76
Materials approaches for modulating neural tissue responses to implanted microelectrodes through mechanical and biochemical means. Curr Opin Solid State Mater Sci (2014) 0.75
Mimicking Neural Stem Cell Niche by Biocompatible Substrates. Stem Cells Int (2016) 0.75
Agarose hydrogels embedded with pH-responsive diblock copolymer micelles for triggered release of substances. Biomacromolecules (2013) 0.75
Three Dimensional Conjugation of Recombinant N-Cadherin to a Hydrogel for In Vitro Anisotropic Neural Growth. J Mater Chem B Mater Biol Med (2016) 0.75
A biosynthetic nerve guide conduit based on silk/SWNT/fibronectin nanocomposite for peripheral nerve regeneration. PLoS One (2013) 0.75
Drug sorption onto and release from soy protein fibers. J Mater Sci Mater Med (2009) 0.75
Use of Erythropoietin as adjuvant therapy in nerve reconstruction. Langenbecks Arch Surg (2008) 0.75
Invasive Intraneural Interfaces: Foreign Body Reaction Issues. Front Neurosci (2017) 0.75
Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol (2003) 14.87
Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci (2001) 11.40
Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature (2002) 8.22
BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol (2005) 4.34
Photopolymerizable hydrogels for tissue engineering applications. Biomaterials (2002) 3.71
Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials (1996) 3.66
cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med (2004) 3.65
Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A (2002) 3.35
Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron (2004) 2.76
Stimulation of neurite outgrowth using an electrically conducting polymer. Proc Natl Acad Sci U S A (1997) 2.74
Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater (2003) 2.66
Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release (2000) 2.33
Analysis of upper and lower extremity peripheral nerve injuries in a population of patients with multiple injuries. J Trauma (1998) 2.23
Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J Neurosci (2003) 2.23
Conjugate addition reactions combined with free-radical cross-linking for the design of materials for tissue engineering. Biomacromolecules (2001) 2.15
Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J Neurosci (2004) 2.14
Incidence of mild and moderate brain injury in the United States, 1991. Brain Inj (1996) 2.12
Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J Neurosci (1997) 2.07
Three-dimensional growth and function of neural tissue in degradable polyethylene glycol hydrogels. Biomaterials (2005) 2.02
Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Ann Neurol (1989) 2.01
Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J Neurosci (2006) 1.99
Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res Brain Res Rev (2000) 1.96
Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide material. Biomaterials (2005) 1.93
Agarose gel stiffness determines rate of DRG neurite extension in 3D cultures. Biomaterials (2001) 1.90
Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. J Control Release (2000) 1.87
Polyethylene glycol-coated biocompatible surfaces. J Biomed Mater Res (2000) 1.85
Fabrication and biocompatibility of polypyrrole implants suitable for neural prosthetics. Biomaterials (2005) 1.78
Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials (2006) 1.78
Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation. Acta Biomater (2005) 1.62
Electrochemically controlled release of dexamethasone from conducting polymer polypyrrole coated electrode. J Control Release (2005) 1.62
Evaluation of biocompatibility of polypyrrole in vitro and in vivo. J Biomed Mater Res A (2004) 1.59
Protein delivery from materials formed by self-selective conjugate addition reactions. J Control Release (2001) 1.58
Poly(ethylene glycol)-containing hydrogels in drug delivery. J Control Release (1999) 1.55
Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. Bioconjug Chem (1999) 1.51
Controlled release of nerve growth factor enhances sciatic nerve regeneration. Exp Neurol (2003) 1.49
Controlled and modulated release of basic fibroblast growth factor. Biomaterials (1991) 1.48
In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury. Biomaterials (2005) 1.45
Immobilized nerve growth factor and microtopography have distinct effects on polarization versus axon elongation in hippocampal cells in culture. Biomaterials (2006) 1.36
Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. J Control Release (2004) 1.32
Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials (2005) 1.32
Polylysine-functionalised thermoresponsive chitosan hydrogel for neural tissue engineering. Biomaterials (2006) 1.32
Incorporation of heparin-binding peptides into fibrin gels enhances neurite extension: an example of designer matrices in tissue engineering. FASEB J (1999) 1.30
The promotion of oriented axonal regrowth in the injured spinal cord by alginate-based anisotropic capillary hydrogels. Biomaterials (2006) 1.30
Freeze-dried poly(D,L-lactic acid) macroporous guidance scaffolds impregnated with brain-derived neurotrophic factor in the transected adult rat thoracic spinal cord. Biomaterials (2004) 1.29
Immobilized concentration gradients of neurotrophic factors guide neurite outgrowth of primary neurons in macroporous scaffolds. Tissue Eng (2006) 1.28
Defining the concentration gradient of nerve growth factor for guided neurite outgrowth. Neuroscience (2001) 1.27
Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation. Biomaterials (2001) 1.27
Nerve growth factor: structure and function. Cell Mol Life Sci (2001) 1.25
GDNF and NGF released by synthetic guidance channels support sciatic nerve regeneration across a long gap. Eur J Neurosci (2002) 1.25
An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury. Exp Neurol (2006) 1.25
Functional regeneration of chronically injured sensory afferents into adult spinal cord after neurotrophin gene therapy. J Neurosci (2001) 1.23
Nerve growth factor-immobilized polypyrrole: bioactive electrically conducting polymer for enhanced neurite extension. J Biomed Mater Res A (2007) 1.23
PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor. J Biomater Sci Polym Ed (2006) 1.20
Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels. Biomaterials (2005) 1.19
Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury. J Control Release (2006) 1.19
Controlled release of anti-inflammatory agent alpha-MSH from neural implants. J Control Release (2005) 1.17
Neurotrophin releasing single and multiple lumen nerve conduits. J Control Release (2005) 1.17
Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration. Biomaterials (1998) 1.16
Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices. J Biomed Mater Res A (2007) 1.15
Development of growth factor fusion proteins for cell-triggered drug delivery. FASEB J (2001) 1.13
A novel star PEG-derived surface coating for specific cell adhesion. J Biomed Mater Res A (2005) 1.13
The effect of polypyrrole with incorporated neurotrophin-3 on the promotion of neurite outgrowth from auditory neurons. Biomaterials (2006) 1.11
In vivo evaluation of poly(L-lactic acid) porous conduits for peripheral nerve regeneration. Biomaterials (1999) 1.10
Synthetic hydrogel guidance channels facilitate regeneration of adult rat brainstem motor axons after complete spinal cord transection. J Neurotrauma (2004) 1.09
Hyaluronic acid-poly-D-lysine-based three-dimensional hydrogel for traumatic brain injury. Tissue Eng (2005) 1.09
Controlling cell adhesion and degradation of chitosan films by N-acetylation. Biomaterials (2005) 1.09
Neutralization of ciliary neurotrophic factor reduces astrocyte production from transplanted neural stem cells and promotes regeneration of corticospinal tract fibers in spinal cord injury. J Neurosci Res (2006) 1.08
Biocompatibility of methylcellulose-based constructs designed for intracerebral gelation following experimental traumatic brain injury. Biomaterials (2001) 1.08
Tissue-engineered scaffolds are effective alternatives to autografts for bridging peripheral nerve gaps. Tissue Eng (2003) 1.06
A collagen-based nerve guide conduit for peripheral nerve repair: an electrophysiological study of nerve regeneration in rodents and nonhuman primates. J Comp Neurol (1991) 1.06
A tissue-engineered conduit for peripheral nerve repair. Arch Otolaryngol Head Neck Surg (1998) 1.06
Collagen containing neurotrophin-3 (NT-3) attracts regrowing injured corticospinal axons in the adult rat spinal cord and promotes partial functional recovery. Exp Neurol (1998) 1.05
Distribution of nerve growth factor following direct delivery to brain interstitium. Brain Res (1995) 1.05
Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model. J Control Release (2006) 1.04
Production of artificial-orientated mats and strands from plasma fibronectin: a morphological study. Biomaterials (1993) 1.04
The influence of physical structure and charge on neurite extension in a 3D hydrogel scaffold. J Biomater Sci Polym Ed (1998) 1.03
Bioengineered strategies for spinal cord repair. J Neurotrauma (2006) 1.03
Glial cell line-derived neurotrophic factor released by synthetic guidance channels promotes facial nerve regeneration in the rat. J Neurosci Res (2002) 1.02
Hydrogel-based three-dimensional matrix for neural cells. J Biomed Mater Res (1995) 1.01
Binding and release of basic fibroblast growth factor from heparinized collagen matrices. Biomaterials (2001) 1.00
Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems. Pharm Res (1999) 1.00
Matrix inclusion within synthetic hydrogel guidance channels improves specific supraspinal and local axonal regeneration after complete spinal cord transection. Biomaterials (2005) 1.00
Neurotrophin-eluting hydrogel coatings for neural stimulating electrodes. J Biomed Mater Res B Appl Biomater (2007) 1.00
Characterization of non-neuronal elements within fibronectin mats implanted into the damaged adult rat spinal cord. Biomaterials (2005) 0.98
Proliferation and differentiation of human embryonic germ cell derivatives in bioactive polymeric fibrous scaffold. J Biomater Sci Polym Ed (2005) 0.98
Optimising the incorporation and release of a neurotrophic factor using conducting polypyrrole. J Control Release (2006) 0.97
Effects of fibinolysis on neurite growth from dorsal root ganglia cultured in two- and three-dimensional fibrin gels. J Comp Neurol (1996) 0.97
The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin. J Neurosci Methods (2005) 0.97
Physiological function and putative therapeutic impact of the FGF-2 system in peripheral nerve regeneration--lessons from in vivo studies in mice and rats. Brain Res Rev (2006) 0.96
Rapid morphological fusion of severed myelinated axons by polyethylene glycol. Proc Natl Acad Sci U S A (1990) 0.96
Alginate enhances elongation of early regenerating axons in spinal cord of young rats. Tissue Eng (2004) 0.95
Thermoreversible laminin-functionalized hydrogel for neural tissue engineering. J Biomed Mater Res A (2006) 0.95
Development of rationally designed affinity-based drug delivery systems. Acta Biomater (2005) 0.94
Stabilizing electrode-host interfaces: a tissue engineering approach. J Rehabil Res Dev (2001) 0.94
Chitin-based tubes for tissue engineering in the nervous system. Biomaterials (2005) 0.94
Incorporation of protein-eluting microspheres into biodegradable nerve guidance channels for controlled release. J Control Release (2005) 0.92
Fluid shear in viscous fibronectin gels allows aggregation of fibrous materials for CNS tissue engineering. Biomaterials (2004) 0.92
Anti-inflammatory drug delivery from hyaluronic acid hydrogels. J Biomater Sci Polym Ed (2004) 0.92
Nerve growth factor- and neurotrophin-3-releasing guidance channels promote regeneration of the transected rat dorsal root. Exp Neurol (2001) 0.92
Clinical long-term in vivo evaluation of poly(L-lactic acid) porous conduits for peripheral nerve regeneration. J Biomater Sci Polym Ed (2000) 0.91
The differentiation of embryonic stem cells seeded on electrospun nanofibers into neural lineages. Biomaterials (2008) 1.58
Controlled release of nerve growth factor enhances sciatic nerve regeneration. Exp Neurol (2003) 1.49
Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. J Control Release (2004) 1.32
Neurite outgrowth on nanofiber scaffolds with different orders, structures, and surface properties. ACS Nano (2009) 1.28
The effects of soluble growth factors on embryonic stem cell differentiation inside of fibrin scaffolds. Stem Cells (2007) 1.23
The early effects of sustained platelet-derived growth factor administration on the functional and structural properties of repaired intrasynovial flexor tendons: an in vivo biomechanic study at 3 weeks in canines. J Hand Surg Am (2007) 1.22
Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury. J Control Release (2006) 1.19
Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices. J Biomed Mater Res A (2007) 1.15
Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI. Soft Matter (2010) 1.09
Affinity-based release of glial-derived neurotrophic factor from fibrin matrices enhances sciatic nerve regeneration. Acta Biomater (2008) 1.08
The effect of controlled growth factor delivery on embryonic stem cell differentiation inside fibrin scaffolds. Stem Cell Res (2008) 1.06
Fibrin-based tissue engineering scaffolds enhance neural fiber sprouting and delay the accumulation of reactive astrocytes at the lesion in a subacute model of spinal cord injury. J Biomed Mater Res A (2010) 1.06
Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI. Cell Transplant (2009) 1.04
Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model. J Control Release (2006) 1.04
Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury. Biotechnol Bioeng (2009) 1.01
BMP12 induces tenogenic differentiation of adipose-derived stromal cells. PLoS One (2013) 1.00
Anisotropic mechanical properties of magnetically aligned fibrin gels measured by magnetic resonance elastography. J Biomech (2009) 1.00
Cell therapy for spinal cord regeneration. Adv Drug Deliv Rev (2007) 0.99
Differential gene expression in motor and sensory Schwann cells in the rat femoral nerve. J Neurosci Res (2011) 0.95
Development of rationally designed affinity-based drug delivery systems. Acta Biomater (2005) 0.94
Controlled release of glial-derived neurotrophic factor from fibrin matrices containing an affinity-based delivery system. J Biomed Mater Res A (2009) 0.93
The effect of endosomal escape peptides on in vitro gene delivery of polyethylene glycol-based vehicles. J Gene Med (2008) 0.93
Fibrin matrices with affinity-based delivery systems and neurotrophic factors promote functional nerve regeneration. Biotechnol Bioeng (2010) 0.93
Conductive Core-Sheath Nanofibers and Their Potential Application in Neural Tissue Engineering. Adv Funct Mater (2009) 0.92
The early inflammatory response after flexor tendon healing: a gene expression and histological analysis. J Orthop Res (2014) 0.92
Schwann cells seeded in acellular nerve grafts improve functional recovery. Muscle Nerve (2013) 0.89
Combination therapies in the CNS: engineering the environment. Neurosci Lett (2012) 0.88
A systematic evaluation of Schwann cell injection into acellular cold-preserved nerve grafts. J Neurosci Methods (2011) 0.88
Transgenic enrichment of mouse embryonic stem cell-derived progenitor motor neurons. Stem Cell Res (2011) 0.86
Release rate controls biological activity of nerve growth factor released from fibrin matrices containing affinity-based delivery systems. J Biomed Mater Res A (2008) 0.85
Generation of v2a interneurons from mouse embryonic stem cells. Stem Cells Dev (2014) 0.85
Engineering peripheral nerve repair. Curr Opin Biotechnol (2013) 0.84
Heparin-binding-affinity-based delivery systems releasing nerve growth factor enhance sciatic nerve regeneration. J Biomater Sci Polym Ed (2010) 0.82
Controlled delivery of glial cell line-derived neurotrophic factor enhances motor nerve regeneration. J Hand Surg Am (2010) 0.81
A microdevice platform for visualizing mitochondrial transport in aligned dopaminergic axons. J Neurosci Methods (2012) 0.81
Synthesis and characterization of four-arm poly(ethylene glycol)-based gene delivery vehicles coupled to integrin and DNA-binding peptides. Mol Pharm (2007) 0.80
A new method for generating high purity motoneurons from mouse embryonic stem cells. Biotechnol Bioeng (2014) 0.80
Development of novel poly(ethylene glycol)-based vehicles for gene delivery. Biotechnol Bioeng (2007) 0.79
Viral transduction of primary Schwann cells using a Cre-lox system to regulate GDNF expression. Biotechnol Bioeng (2014) 0.77
Characterization of a multifunctional PEG-based gene delivery system containing nuclear localization signals and endosomal escape peptides. Acta Biomater (2008) 0.77
Kinetic analysis of neurotrophin-3-mediated differentiation of embryonic stem cells into neurons. Tissue Eng Part A (2009) 0.76
Analysis of cell binding and internalization of multivalent PEG-based gene delivery vehicles. IEEE Trans Nanobioscience (2011) 0.76
Abstract 91: Engineering Primary Schwann Cells using Lentiviruses to Control GDNF Expression. Plast Reconstr Surg (2014) 0.75
Getting your research out there: open access & more. Ann Biomed Eng (2012) 0.75
Effects of borate-based bioactive glass on neuron viability and neurite extension. J Biomed Mater Res A (2013) 0.75